Patents Examined by Hydsuk Kim
  • Patent number: 5639727
    Abstract: The present invention provides therapeutic methods for treatment of conditions including the neutralization of the anti-coagulant activity of heparin, inhibition of angiogenesis, tumor and endothelial cell proliferation, and treatment of chronic inflammatory diseases by administration of bactericidal/permeability-increasing (BPI) protein products.
    Type: Grant
    Filed: March 31, 1995
    Date of Patent: June 17, 1997
    Assignee: XOMA Corporation
    Inventor: Roger G. Little, II